Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia
Objective: The clinical and neuroimaging factors associated with dysphagia were investigated in this retrospective data of Parkinson's disease (PD) patients. Background: PD can cause dysphagia…Does age at onset of Parkinson’s disease affect the development of dementia?
Objective: To investigate whether progression to dementia in senile Parkinson’s disease, SPD, (disease onset after 70 years) differs from that in old Parkinson’s disease, OPD,…Identification of protein biomarker/s in CSF of Parkinson’s disease (PD) with cognitive impairment
Objective: i. To identify CSF protein biomarker/s in Parkinson's disease (PD) with cognitive impairment using LC-MS/MS proteomics. ii. To estimate the level of known AD…Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease
Objective: We assessed the role of visual measures and retinal volume (in dopaminergic layers: ganglion cell layer (GCL) and inner plexiform layer (IPL)) to predict…Neuroimaging in Parkinson’s disease dementia: Connecting the dots
Objective: To identify the neural substrates of Parkinson’s disease dementia (PDD) and Parkinson’s disease with Mild Cognitive Impairment (PD-MCI) using a network mapping approach. Background:…The effect of baseline cognitive status of Parkinson’s disease on the outcome after deep brain stimulation surgery
Objective: To evaluate the effect of baseline cognitive status of Parkinson’s disease (PD) on the outcome after deep brain stimulation (DBS) surgery. Background: Advanced dementia…Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson’s Disease
Objective: To investigate whether Parkinson’s disease (PD) cognitive states and phenotypes are associated with changes in prevalence and severity of Impulse control disorder (ICD). Background:…Cortical FDG-PET patterns predict long-term motor progression and disability milestones in Parkinson’s disease
Objective: To evaluate the accuracy of single-subject FDG-PET in predicting motor and cognitive long-term progression in Parkinson's disease Background: The progression of Parkinson's disease is…Introduction of an Assessment Toolkit Increases the Rate of DLB Diagnosis
Objective: To assess whether diagnostic rates of both Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) could be increased by the introduction of…A phase IIa trial studying the safety and tolerability of IRL752 in patients with Parkinson’s disease dementia
Objective: The primary objective was to investigate the safety and tolerability of IRL752 in PD patients with dementia in a randomized controlled trial. Secondary outcome…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 36
- Next Page »